These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34082086)

  • 1. Risk factors for and management of metronidazole-refractory giardiasis in international travellers: A retrospective analysis.
    Peters TE; Kreuels B; Addo MM; Tannich E; Rothe C
    Travel Med Infect Dis; 2021; 43():102090. PubMed ID: 34082086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
    Carter ER; Nabarro LE; Hedley L; Chiodini PL
    Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.
    Nabarro LE; Lever RA; Armstrong M; Chiodini PL
    Clin Microbiol Infect; 2015 Aug; 21(8):791-6. PubMed ID: 25975511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review.
    Bourque DL; Neumayr A; Libman M; Chen LH
    J Travel Med; 2022 Jan; 29(1):. PubMed ID: 34350966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
    Cañete R; Noda AL; Rodríguez M; Brito K; Herrera E; Kofoed PE; Ursing J
    Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory giardiasis in Spanish travellers.
    Muñoz Gutiérrez J; Aldasoro E; Requena A; Comin AM; Pinazo MJ; Bardají A; Oliveira I; Valls ME; Gascon J
    Travel Med Infect Dis; 2013; 11(2):126-9. PubMed ID: 23218784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of patients with refractory giardiasis.
    Nash TE; Ohl CA; Thomas E; Subramanian G; Keiser P; Moore TA
    Clin Infect Dis; 2001 Jul; 33(1):22-8. PubMed ID: 11389490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giardiasis: report of a case refractory to treatment.
    Iza JA; Iza SN; Olivera MJ
    Infez Med; 2019 Sep; 27(3):336-339. PubMed ID: 31545780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giardiasis: An Overview.
    Leung AKC; Leung AAM; Wong AHC; Sergi CM; Kam JKM
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(2):134-143. PubMed ID: 31210116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis.
    Solaymani-Mohammadi S; Genkinger JM; Loffredo CA; Singer SM
    PLoS Negl Trop Dis; 2010 May; 4(5):e682. PubMed ID: 20485492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giardiasis: a pharmacotherapy review.
    Escobedo AA; Cimerman S
    Expert Opin Pharmacother; 2007 Aug; 8(12):1885-902. PubMed ID: 17696791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giardiasis treatment: an update with a focus on refractory disease.
    Mørch K; Hanevik K
    Curr Opin Infect Dis; 2020 Oct; 33(5):355-364. PubMed ID: 32773501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Giardia lamblia as a rare cause of reactive arthritis].
    Krol A
    Ugeskr Laeger; 2013 Dec; 175(49A):V05130347. PubMed ID: 25353256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.
    Lemée V; Zaharia I; Nevez G; Rabodonirina M; Brasseur P; Ballet JJ; Favennec L
    J Antimicrob Chemother; 2000 Nov; 46(5):819-21. PubMed ID: 11062206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiprotozoal effect of steroid hormone 20-hydroxyecdysone in giardiosis patients.
    Toychiev A; Kerimov F; Islamova J; Shaislamova M; Mirzakhmedov M; Davis N; Syrov V; Osipova S
    Ann Parasitol; 2022; 68(3):605-615. PubMed ID: 36617399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study.
    Neumayr A; Schunk M; Theunissen C; Van Esbroeck M; Mechain M; Hatz C; Mørch K; Soriano Pérez MJ; Sydow V; Sothmann P; Kuenzli E; Rothe C; Bottieau E
    Clin Infect Dis; 2021 Oct; 73(8):1517-1523. PubMed ID: 34115100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saccharomyces boulardii as therapeutic alternative in experimental giardiasis.
    Ribeiro MRS; Oliveira DR; Caliari MV; Cara Machado DC; Andrade MER; Cardoso VN; Dos Santos Martins F; Nicoli JR; Gomes MA
    J Appl Microbiol; 2021 Jul; 131(1):460-469. PubMed ID: 33289232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of refractory paediatric giardiasis using secnidazole plus albendazole: a case series.
    Escobedo AA; Almirall P; Chirino E; Pacheco F; Duque A; Avila I
    Infez Med; 2018 Dec; 26(4):379-384. PubMed ID: 30555145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of recurring symptoms after infection with Giardia lamblia in a non-endemic area.
    Wensaas KA; Langeland N; Rortveit G
    Scand J Prim Health Care; 2009; 27(1):12-7. PubMed ID: 19085428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Giardia lamblia infection in children with recurrent abdominal pain.
    Younas M; Shah S; Talaat A
    J Pak Med Assoc; 2008 Apr; 58(4):171-4. PubMed ID: 18655423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.